BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2662090)

  • 1. Immunohistochemical study of ras p21 expression in human gastric cancers and benign lesions.
    Nakajima K; Kuzumaki N; Oda A; Kobayashi H; Katoh H; Tanabe T
    Oncology; 1989; 46(4):260-5. PubMed ID: 2662090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunohistochemical study of ras p21 expression in human gastric cancers and benign lesions].
    Nakajima K
    Hokkaido Igaku Zasshi; 1987 Jul; 62(4):573-80. PubMed ID: 3315926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced expression of c-Ha-ras p21 in human stomach adenocarcinomas defined by immunoassays using monoclonal antibodies and in situ hybridization.
    Ohuchi N; Hand PH; Merlo G; Fujita J; Mariani-Costantini R; Thor A; Nose M; Callahan R; Schlom J
    Cancer Res; 1987 Mar; 47(5):1413-20. PubMed ID: 2434216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of ras oncogene p21 protein in early gastric carcinoma and adjacent gastric epithelia.
    Czerniak B; Herz F; Gorczyca W; Koss LG
    Cancer; 1989 Oct; 64(7):1467-73. PubMed ID: 2550123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ras oncogene p21 as a tumor marker in the cytodiagnosis of gastric and colonic carcinomas.
    Czerniak B; Herz F; Koss LG; Schlom J
    Cancer; 1987 Nov; 60(10):2432-6. PubMed ID: 3311346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical demonstration of ras p21 oncogene product in normal, benign, and malignant human thyroid tissues.
    Mizukami Y; Nonomura A; Hashimoto T; Terahata S; Matsubara F; Michigishi T; Noguchi M
    Cancer; 1988 Mar; 61(5):873-80. PubMed ID: 3276392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of Ha-ras oncogene product, p21 in gastric carcinoma].
    Ebihara T; Koyama S; Osuga T
    Nihon Shokakibyo Gakkai Zasshi; 1987 Sep; 84(9):1737-9. PubMed ID: 3323578
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of the ras and myc oncoproteins in benign gastric lesions.
    Karayiannis M; Yiagnisis M; Papadimitriou K; Field JK; Spandidos DA
    Anticancer Res; 1990; 10(5A):1127-33. PubMed ID: 2241094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ras p21 oncoprotein expression in human colonic neoplasia--an immunohistochemical study with monoclonal antibody RAP-5.
    Lanza G
    Histopathology; 1988 Jun; 12(6):595-609. PubMed ID: 3047043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression of ras oncogene product P21 in thyroid tumors: an immunohistochemical study].
    Gui K
    Zhonghua Yi Xue Za Zhi; 1990 Mar; 70(3):140-2, 12. PubMed ID: 2163739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative immunohistochemical reactivity of monoclonal and polyclonal antibodies to H-ras p21 in normal and neoplastic tissues of rodents and humans.
    Ward JM; Perantoni AO; Santos E
    Oncogene; 1989 Feb; 4(2):203-13. PubMed ID: 2648257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunohistochemical study of oncogene-related products in human gastrointestinal malignancies--expression of ras p 21, fes p 85 and EGF receptor].
    Kitagami S; Itabashi M; Hirota T; Hayashi I; Hojo K; Moriya Y; Maruyama K; Okabayashi K
    Gan No Rinsho; 1986 Dec; 32(15):1950-8. PubMed ID: 2433473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical analysis of the ras oncogene protein product in human thyroid neoplasms.
    Papadimitriou K; Yiagnisis M; Tolis G; Spandidos DA
    Anticancer Res; 1988; 8(6):1223-7. PubMed ID: 3064713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histologic demonstration of antigens reactive with anti-p21 ras monoclonal antibody (RAP-5) in human stomach cancers.
    Noguchi M; Hirohashi S; Shimosato Y; Thor A; Schlom J; Tsunokawa Y; Terada M; Sugimura T
    J Natl Cancer Inst; 1986 Aug; 77(2):379-85. PubMed ID: 3525957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation of anti-ras Mr 21,000 protein monoclonal antibodies and immunohistochemical analyses on expression of ras genes in human stomach and thyroid cancers.
    Yoshida K; Hamatani K; Koide H; Ikeda H; Nakamura N; Akiyama M; Tsuchiyama H; Nakayama E; Shiku H
    Cancer Res; 1988 Oct; 48(19):5503-9. PubMed ID: 3046740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [An attempt at using monoclonal antibodies to oncogene products].
    Kuzumaki N
    Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 2):2205-11. PubMed ID: 3300558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of c-myc oncogene product and ras family oncogene products in various human malignant lymphomas defined by immunohistochemical techniques.
    Mitani S; Sugawara I; Shiku H; Mori S
    Cancer; 1988 Nov; 62(10):2085-93. PubMed ID: 3052780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunohistochemical studies of ras oncogene product p21 in human ovarian tumors].
    Yaginuma Y; Yamashita K
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Sep; 41(9):1409-16. PubMed ID: 2685141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal preservation of p21 ras immunoreactivity and morphology in paraffin-embedded tissue.
    Going JJ; Williams AR; Wyllie AH; Anderson TJ; Piris J
    J Pathol; 1988 Jul; 155(3):185-90. PubMed ID: 3045276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of ras gene expression in stomach cancer by anti-ras p21 monoclonal antibodies.
    Yoshida K; Hamatani K; Koide H; Abe Y; Ikeda H; Tsuchiyama H; Nakayama E; Shiku H
    Cancer Detect Prev; 1988; 12(1-6):369-76. PubMed ID: 3052835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.